Political Pressure Unravels FDA Peptide Safeguards

The FDA is being pressured by Health Secretary RFK Jr. to lift restrictions on 12 unproven peptides without significant new safety evidence, raising concerns about how political influence can override scientific judgment in drug regulation. This case highlights the growing tension between the wellness industry's commercial interests and public health oversight, with potential consequences for consumer safety.